AZTREONAM Principal Display Panel (aztreonam for injection, USP)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label

NDC 0409-0829-11
Rx Only

Aztreonam for
Injection, USP
1 gram/vial

For Intravenous or Intramuscular use after constitution.

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton

10 x 1 gram Single-Dose Vials

NDC 0409-0829-01
Contains 10 of NDC 0409-0829-11

Aztreonam
for Injection, USP
1 gram/vial

For Intravenous or Intramuscular use after constitution.

Rx only

Hospira

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton

PRINCIPAL DISPLAY PANEL - 2 gram Vial Label

NDC 0409-0830-11

Aztreonam
for Injection, USP
2 grams/vial

For Intravenous or Intramuscular
use after constitution.

Rx Only

Hospira

PRINCIPAL DISPLAY PANEL - 2 gram Vial Label

PRINCIPAL DISPLAY PANEL - 2 gram Vial Carton

10 x 2 grams Single-Dose Vials

NDC 0409-0830-01
Contains 10 of NDC 0409-0830-11

Aztreonam
for Injection, USP
2 grams/vial

For Intravenous or Intramuscular use after constitution.

Rx only

Hospira

PRINCIPAL DISPLAY PANEL - 2 gram Vial Carton

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

AZTREONAM Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.

If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

INDICATIONS AND USAGE

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Aztreonam for Injection, USP and other antibacterial drugs, aztreonam for injection should be used only to treat or...